医用件证书凑齐了，生物相容性一测还是不过。医疗级TPE，证书齐了，件也未必过得去。
翻车现场：医疗件翻车，翻在“证书齐了，件没过”
医疗 TPE 的翻车，最常见的是三种：
现场一：材料 ISO10993 证书齐全，但注塑件做细胞毒性不过——材料级合规不等于成品级合规，加工过程会引入新变量；现场二：
用了含 DEHP 的 PVC 或违规增塑剂体系，出口被拒——无 DEHP 是底线，不是加分项；现场三：软度够了，回弹不够，导管压瘪回不来——**医疗 TPE 的硬度标尺，
比普通行业细得多。
**
生物相容性测试还有个“测试机构”的门道：ISO 10993 系列测试要找有资质的第三方（如 CMA/CNAS 认可）做，报告才被监管认可。
采购时把检测机构资质一起核——机构没资质，报告再全也是废纸。
医疗级 TPE 的“细胞毒性”常被低估：注塑温度过高、助剂析出，都会让细胞毒性超标。
选料时把“加工耐受性”写进要求——同一牌号，工艺不当照样过不了测试，别只盯材料本身。
医疗件的“试错成本”是行业里最高的：消费电子选错料，返工一批；医疗件选错料，是召回、是临床事故、是监管处罚。
所以医疗 TPE 的流程永远比别的行业慢半拍——不是效率低，是每一步都要留证据。
医疗件的留样制度也特殊：材料留样、成品留样、灭菌后留样，三个环节都要留。
出了客诉能逐环节排查——不留样的，出了问题只能靠猜，猜错的代价是召回。
医疗 TPE 的“批次追溯”要做到“件级”：每批材料对应哪批成品、哪批灭菌记录，要能串起来。
追溯链断一环，出问题就只能整批报废——追溯系统，是医疗件的最低配置。
原因拆解：医疗 TPE 的三个特殊
特殊一 · 生物相容性：ISO 10993 是一整套测试（细胞毒性、致敏、刺激、全身毒性等），不是一张证书。
材料级过了，成品级还要过——注塑助剂、脱模剂、清洗剂都可能引入风险。
测试范围按接触类型分级：皮肤表面接触做细胞毒性和皮肤刺激即可；接触黏膜、短期接触血液的，
要加致敏和急性全身毒性。
按接触时间选组合，不是做得越多越好。
特殊二 · 增塑剂红线：DEHP 等邻苯类增塑剂在医疗场景（输液、采血、导管）被严格限制，无 DEHP 体系是硬底线。
选择 SEBS 基等本身不含增塑剂的体系，比“加增塑剂再宣称合规”稳妥得多。
DEHP 之外，还有一批邻苯类增塑剂在医疗场景受限（DINP、DBP 等）——“无 DEHP”不等于“无邻苯”。
选型时把目标市场的限制清单要来，逐项核对助剂体系，比只认“无 DEHP”三个字稳妥。
医疗级 TPE 的“灭菌成本”要算：EO 灭菌有解析时间（通风除残），γ 辐照有辐照费，蒸汽灭菌对材料耐湿热要求高。
三种灭菌方式的成本和时间不同——选型时把灭菌方式定下来，成本和验证周期才估得准。
特殊三 · 灭菌兼容：医疗件要过灭菌——环氧乙烷（EO）、γ 射线、蒸汽。
不同灭菌方式对 TPE 的要求完全不同：EO 灭菌看材料对环氧乙烷的吸附和解析，γ 辐照看耐辐射性，蒸汽看耐湿热。
选型时把灭菌方式写进工况，是医疗 TPE 的入门动作。
排查步骤：医疗件四步过检
医疗级 TPE 的“硬度标尺”比普通行业细：导管要软（回弹好、不易压瘪），塞子要中等（密封和插入平衡），手柄要硬（握持稳定）。
硬度标尺图的价值，是把“手感要求”翻译成“可验收的 Shore 值”——写不清硬度，就定不了牌号。
医疗级 TPE 的“配色”也有限制：医疗件常用浅色、透明色，颜料和色母的迁移、析出都要评估。
深色遮盖力强但可能含金属颜料，医疗场景要慎用——配色方案提前和材料一起验证。
- 1. 定场景：接触血液/药液/皮肤？接触时间多长？——接触类型决定生物相容性测试等级；
- 2. 查体系：是否无 DEHP？助剂体系是否干净？——SEBS 基优先，不靠增塑剂凑软度；
- 3. 对硬度：用硬度标尺图对号——导管、塞子、密封圈各要各的软硬档；
- 4. 做成品验证：材料证书 + 成品测试一起看——别拿材料级报告当成品级结论。
| 医疗件 | 典型硬度 | 关键要求 |
|---|
| 输液导管 | 55-70A | 无DEHP、生物相容 |
| 密封塞 | 30-45A | 回弹、密封 |
| 手术器械手柄 | 70-90A | 灭菌兼容 |
| 医用垫片 | 50-60A | 耐化学、无析出 |
技术金句：医疗级 TPE 的选型，是把“材料合规”翻译成“成品合规”——证书只是入场券，成品验证才是终审。
过检卡住怎么救：料、配方、工艺三处改
医疗件的“洁净度”还影响生物相容性：注塑车间的尘埃、脱模剂残留、包装材料的析出物，都可能让成品测试不过。
选料之外，洁净生产管理是医疗 TPE 项目的第二战场——材料干净，工艺也要干净。
料的方向：选无 DEHP 的 SEBS 基/TPV 体系，软度靠分子量调节和食品级白油，不靠增塑剂；要求耐化学、耐灭菌的，考虑 TPV 或 TPEE 体系。
配方的方向：助剂清单要干净——抗氧剂、润滑剂的选择都要评估生物相容性；有灭菌要求的，配方要针对灭菌方式调整。
工艺的方向：医疗件洁净生产——车间洁净度、脱模剂选用、后处理（清洗、干燥、包装）都要纳入验证。
工艺引入的污染，和材料本身的问题一样致命。
医疗料到货查这三项，生物相容必看
- 1. 查证书时效：ISO 10993 报告的有效期和适用条款，要覆盖你的接触类型；
- 2. 查成品测试：用实际注塑件做生物相容性/灭菌验证，不留粒料级报告充数；
- 3. 查变更管理：配方、助剂、工艺任何变动，都要重新走验证——供应商没有变更管理流程的，要打问号。
| 等级 | 用途 | 判断 |
|---|
| 医疗级 | 人体接触 | 必备 |
| 器械级 | 外部件 | 按需 |
| 工业级 | 非接触 | 不选 |
| 项目 | 要求 | 判断 |
|---|
| ISO10993 | 达标 | 必备 |
| 无 DEHP | 达标 | 必备 |
| 生物相容 | 实测 | 必备 |
| 批次 | 可溯 | 必备 |
科隆客户案例：批次色差频被投诉，换体系换牌号压到 7 天
常州一家线缆厂，医疗级 TPE 线缆批次色差明显，频繁被客户投诉。科隆配合换体系换牌号（SEBS 基换 TPV 基），同步调整工艺窗口，交付周期压缩到 7 天内。
换的不是牌号，是体系的适配逻辑——同一场景，不同体系各有主场。
小结
医疗级 TPE 的“供应商审计”频率要高：医疗项目建议每年审一次供应商——配方变更、产线变动、人员流动都影响批次一致性。审计不是走形式，是给追溯链上保险。
医疗级 TPE 的“文件包”要成套：材料规格书、检测报告、成分声明、变更记录，一套四件缺一不可。审厂时先看文件包，再看产线——文件齐的供应商，管理不会差到哪去。
医疗级 TPE 的“行业提醒”：医疗集采、注册新规下，材料合规的权重在上升。选料时把“注册支持”当成供应商能力的一部分——能陪你走完注册的材料商，才是长期伙伴。
医疗级 TPE 的选型，值得你多花十分钟想清楚——证书、体系、灭菌、成品验证，四件事一次对齐。
医疗 TPE 的“成本认知”要正：医疗级料比普通料贵，贵在品控和合规投入。但医疗件的报废成本、召回成本更高——算总账，医疗级的贵是省钱的贵。
医疗件还有一个“临床反馈”的闭环：材料换了之后，临床使用反馈（手感、操作、并发症）要收集。反馈数据是下一轮选型的依据——医疗选型不是一锤子买卖，是持续迭代。
这一篇的落脚点很简单：医疗级 TPE的选型，值得你多花十分钟想清楚。
十几年，只做一件事：把尼龙改成能用的样子。
PA6、PA66 是基本盘，PA46、PA6T、PA9T 是耐高温的门槛，PA11、PA12 管水路和油路，尼龙合金补单一树脂给不了的平衡。改性热塑性弹性体、改性尼龙、改性 PPO、PPS 并行，还有各大化工巨头的尼龙树脂、副牌料、大包料现货。
同一块料，用错地方就是事故。所以先问件，再问料。
Medical part certificates are collected, but biocompatibility tests still fail. Medical-grade TPE, even if certificates are complete, parts may not pass.
Mishaps: Medical parts fail, with "certificates complete, but parts not approved"
Medical TPE failures are common in three types:
On-site 1: Materials ISO10993 certificates complete, but injection-molded parts do not have cytotoxicity—material-grade compliance does not mean finished product compliance, and processing introduces new variables; On-site 2:
used PVC or illegal plasticizer systems containing DEHP, export rejected—no DEHP is the bottom line, not a bonus; Site 3: Soft enough, insufficient rebound, catheter slumps and can't be restored—**The hardness scale of medical TPE is much finer than that of ordinary industry
.
**
There's also a 'testing institution' trick for biocompatibility testing: ISO 10993 series tests must be conducted by qualified third parties (such as CMA/CNAS accredited) before the report is recognized by regulators.
Check the testing institution's qualifications together during procurement—if the institution isn't qualified, no matter how complete the report is, it's just waste.
The 'cytotoxicity' of medical-grade TPE is often underestimated: excessively high injection temperatures and excessives can cause cytotoxicity to exceed limits.
Include "processing tolerance" in material selection—even if the same grade is poor, it still won't pass testing, so don't focus only on the material itself.
The "trial-and-error cost" for medical devices is the highest in the industry: consumer electronics use the wrong material, resulting in rework; choosing the wrong material for medical devices leads to recalls, clinical accidents, or regulatory penalties.
So the medical TPE process is always half a step behind other industries—not because efficiency is low, but because evidence must be left at every step.
Medical device sample retention system is also special: material sample retention, finished product sample retention, and post-sterilization sample retention — all three steps must be retained.
Investigate every customer complaint step by step—if there's no residue, if something goes wrong, you can only guess, and the price of a wrong guess is a recall.
Medical TPE "batch traceability" must be "case-level": each batch of materials corresponds to which batch of finished product and which batch sterilization records must be linked together.
If the traceability chain is broken, the entire batch must be scrapped—the traceability system is the minimum configuration for medical parts.
Reason Breakdown: The three special features of medical TPE
Special One · Biocompatibility: ISO 10993 is a complete set of tests (cell toxicity, sensitization, irritation, systemic toxicity, etc.), not a certificate.
Material level passes, but finished product level must also pass—injection molding additives, release agents, and cleaning agents may introduce risks.
Testing scope is classified by contact type: skin surface contact for cytotoxicity and skin irritation is sufficient; For contact with mucous membranes or short-term blood exposure,
must add sensitization and acute systemic toxicity.
Select combinations based on contact time; more is not always better.
Special Two · Plasticizer Red Line: DEHP and other phthalic plasticizers are strictly restricted in medical settings (infusion, blood collection, catheters); no DEHP system is a hard bottom line.
Choosing systems without plasticizers such as SEBS is much more reliable than "adding plasticizers and then claiming compliance."
DEHP Besides these, there is also a batch of phthalmogenic plasticizers restricted in medical settings (DINP, DBP, etc.)—"no DEHP" does not mean "no phthalene."
Obtain a list of restrictions from the target market during selection and verify the additive system item by item, which is more reliable than just recognizing "no DEHP."
The "sterilization cost" for medical-grade TPE should be calculated: EO sterilization has a resolution time (ventilation and residual removal), γ irradiation has an irradiation fee, and steam sterilization requires high moisture and heat resistance to the material.
The costs and timing of the three sterilization methods are different—only by defining the sterilization method during selection can cost and validation cycles be accurately estimated.
Special Three · Sterilization Compatible: Medical devices must undergo sterilization—ethylene oxide (EO), γ radiation, and steam.
Different sterilization methods have completely different requirements for TPE: EO sterilization depends on the material's adsorption and resolution of ethylene oxide; γ irradiation, radiation resistance; steam, humidity and heat resistance.
Include the sterilization method in the operating conditions during model selection; this is the basic step for medical TPE.
Inspection steps: Four-step inspection of medical parts
The "hardness scale" of medical-grade TPE is finer than that of ordinary industries: catheters should be soft (good rebound, not prone to collapse), stoppers should be medium (sealing and insertion balanced), and handles should be firm (stable grip).
The value of the hardness scale chart is to translate "tactile feel requirements" into "acceptable Shore values"—if hardness cannot be clearly specified, the grade cannot be determined.
Medical-grade TPE also has limitations in "color matching": medical parts often use light or transparent colors, and pigment and masterbatch migration and precipitation must be evaluated.
Dark colors have strong coverage but may contain metallic pigments; use cautiously in medical settings—verify color schemes together with materials in advance.
- 1. Set the scenario: contact with blood/medication/skin? How long should the contact last? ——The type of contact determines the biocompatibility test level;
- 2. System check: Is there no DEHP? Is the additive system clean? ——SEBS base is prioritized, not relying on plasticizers for softness;
- 3. For hardness: use a hardness scale to mark the difference—catheters, plugs, and sealing rings each have their own softness and hardness;
- 4. Conduct finished product verification: review material certificates + finished product testing together—don't use material-grade reports as the final product conclusion.
| Medical Device | Typical Hardness | Key Requirements |
|---|
| Infusion Catheter | 55-70A | No DEHP, Biocompatible |
| Sealing Stopper | 30-45A | Rebound, Sealing |
| Surgical instrument handles | 70-90A | Sterilization compatibility |
| Medical gaskets | 50-60A | Chemical-resistant, no precipitation |
Technical golden quote: Selecting medical-grade TPE translates "material compliance" into "finished product compliance"—the certificate is just the entry ticket; finished product verification is the final review.
How to fix stuck after inspection: Modifications in materials, formulation, and process
The "cleanliness" of medical parts also affect biocompatibility: dust in the injection molding workshop, release agent residues, and precipitates from packaging materials can all cause the finished product to fail testing.
Beyond material selection, clean production management is the second battlefield of medical TPE projects—clean materials and processes must also be clean.
Material direction: choose SEBS-based/TPV systems without DEHP, with softness adjusted by molecular weight and food-grade white oil, not plasticizers; For chemical and sterile resistance, consider TPV or TPEE systems.
Formulation direction: Additives must be clean—the selection of antioxidants and lubricants must assess biocompatibility; If sterilization is required, the formula should be adjusted according to the sterilization method.
Process direction: Clean production of medical parts—workshop cleanliness, release agent selection, and post-processing (cleaning, drying, packaging) must all be verified.
Contamination introduced by processes is as fatal as problems with the materials themselves.
Medical material arrival check these three items, biocompatibility must be checked
- 1. Check certificate validity: The validity period and applicable terms of the ISO 10993 report should cover your contact type;
- 2. Check finished product testing: Use actual injection-molded parts for biocompatibility/sterilization verification, without filling in the pellet-level report;
- 3. Check change management: Any changes in formulation, additives, or processes must be re-verified—suppliers without change management processes should be questioned.
| Grade | Purpose | Judgment |
|---|
| Medical Grade | Human Contact | Essential |
| Device Grade | External Components | On-Demand |
| Industrial Grade | Non-contact | No Selection |
| Project | Requirement | Judgment |
|---|
| ISO10993 | Qualified | Essential |
| No DEHP | Compliant | Essential |
| Biocompatible | Actual Testing | Essential |
| Batch | Traceable | Essential |
Cologne Customer Case: Batch color difference frequently complained about, system and brand change delayed for 7 days
A cable factory in Changzhou has obvious batch color differences for medical-grade TPE cables, frequently complained about by customers. Cologne switched systems and brands (SEBS to TPV base), synchronously adjusting process windows and reducing delivery cycles to within 7 days.
The change is not about grade, but about system adaptation logic—the same scenario, but different systems have their own domains.
Summary
For medical-grade TPE, "supplier audits" must be frequent: for medical projects, it is recommended to audit suppliers once a year—formula changes, production line changes, and personnel turnover all affect batch consistency. Audits are not just formalities; they provide on-chain insurance for traceability.
The "document package" for medical-grade TPE must be complete: material specifications, test reports, ingredient declarations, change records—all four items are indispensable. During factory audits, first look at the document package, then the production line—suppliers with complete documentation usually have poor management.
Medical-grade TPE's "industry reminder": Under new regulations on medical centralized procurement and registration, the weight of material compliance is rising. When selecting materials, treat "registration support" as part of the supplier's capability—only material suppliers who can accompany you through registration are long-term partners.
Medical-grade TPE selection is worth spending an extra ten minutes thinking through—certificates, systems, sterilization, finished product verification, all four things aligned at once.
Medical TPE's "cost awareness" must be correct: medical-grade materials are more expensive than ordinary materials, mainly due to quality control and compliance investment. But the scrap and recall costs of medical parts are higher—in summary, medical-grade materials are expensive because they save money.
Medical Devices also has a "clinical feedback" closed loop: after material changes, clinical usage feedback (feel, operation, complications) needs to be collected. Feedback data is the basis for the next round of selection—medical selection is not a one-time deal, but continuous iteration.
The goal of this article is simple: selecting medical-grade TPE is worth spending an extra ten minutes thinking through.
For over a decade, only one thing has been done: to make nylon usable.
PA6. PA66 is the foundation; PA46, PA6T, PA9T are the threshold for high-temperature resistance; PA11 and PA12 are for water and oil lines, nylon alloys are balanced that a single resin cannot provide. Modified thermoplastic elastomers, modified nylon, modified PPO, PPS are available in parallel, along with major chemical giants' nylon resin, sub-brand materials, and large packages in stock.
The same piece of material can be used in the wrong place and cause an accident. So ask about the part first, then the material
